Contract sales & marketing

Assessing Pre-Existing Antibodies in Biotheraputic Development

Frontage Laboratories | 21-Aug-2019 | Technical / White Paper

Immunogenicity is the leading reason that biologics fail in clinical trials, and thus it has become imperative for drug development programs to include...

The Truth about Physician Referrals and Clinical Trials

Despite growing evidence, the myth that physicians won’t refer patients to clinical trials persists, perpetuated by the belief that they fear losing their...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 05-Nov-2018 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Survey Report: State of the global pharmaceutical contract services industry 2018

William Reed | 11-Jul-2018 | Research Study

In May 2018 Outsourcing-Pharma.com, in association with InnovoCommerce, conducted its second annual ‘state of the industry’ survey on its user base of...

How will Brexit affect the Pharmaceutical Industry?

Source BioScience Ltd | 08-Mar-2018 | Technical / White Paper

Have you prepared your strategy for the outcome of Brexit to ensure that you can continue to supply the UK market?
Source BioScience is a CRO with...

Survey Report: State of the Global Pharmaceutical Contract Services Industry 2017

William Reed | 27-Jul-2017 | Application Note

In May 2017, Outsourcing-Pharma.com conducted its inaugural “state of the industry” survey of its user base of pharmaceutical industry professionals, including...

The Power to Make, A Virtual Tour

Althea | 24-Mar-2017

You have the power to make a difference. To make new therapeutics that improve quality of life and inspire a healthier world. To do this, you need a manufacturing...

Looking for a prefilled option for your sensitive compound?

Vetter Pharma International GmbH | 12-Apr-2016 | Product Brochure

With more sophisticated therapies coming to market, manufacturers need more options for complex, sensitive molecules. Vetter-Ject® is a patented, ready-to-use...

Innovative Solutions for Biologics Utilizing Advanced Aseptic Processing

Catalent Pharma Solutions | 03-Nov-2015 | Insight Guide

In this Insight Guide, Catalent Pharma Solutions will aim to show you three things:1. Advanced Aseptic Delivery Technology: Blow-Fill-Seal2. General Requirements...

Alkermes’ successful approach to commercial scale final dosage manufacture of drug product containing highly potent API

Alkermes Contract Pharma Services | 17-Mar-2015 | Case Study

With 45 years’ in the service business, Alkermes Contract Pharma Services, has proven expertise in drug process design  improvements, tech transfer and...